Showing results (1401-1410 of 3,886) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|December 1, 2009
Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT)Nir Gefen, Gordana Brkic, Dalia Galron, et al.
Cancer Biology & Therapy|December 23, 2009
Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 casesTiziana Megha, Alessandro Neri, Valeria Malagnino, et al.
Cancer Biology & Therapy|December 22, 2009
Expression of CD133 correlates with differentiation of human colon cancer cellsHai-Liang Feng, Yu-Qin Liu, Li-Juan Yang, et al.
Cancer Biology & Therapy|December 22, 2009
DNA damage signaling is activated during cancer progression in human colorectal carcinomaKazuhito Oka, Toshiki Tanaka, Tadahiko Enoki, et al.
Cancer Biology & Therapy|December 22, 2009
Colorectal tumor derived fibronectin alternatively spliced EDA domain exserts lymphangiogenic effect on human lymphatic endothelial cellsJuan-Juan Ou, Feng Wu, Hou-Jie Liang
Cancer Biology & Therapy|December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesotheliomaSharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Cancer Biology & Therapy|December 30, 2009
Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-RasArunasalam Navaraj, Niklas Finnberg, David T Dicker, et al.
Cancer Biology & Therapy|December 30, 2009
Paradoxical roles for antioxidants in tumor prevention and eradicationJoseph E De Larco, Carissa A Park, Halina Dronava, et al.
Cancer Biology & Therapy|October 27, 2009
A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growthJuho Suojanen, Tuula Salo, Erkki Koivunen, et al.
Cancer Biology & Therapy|October 27, 2009
DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1Jing Zhang, Yan Li, Liang Guo, et al.
Pageof 389